Get started
Author

Emily C. Liang

Observed names: Dr Emily Liang, E. Liang, Emily C Liang, Emily Liang
Observed institutions: Cedars-Sinai Medical Center, University of California, Los Angeles, University of Washington, Fred Hutch Cancer Center, Stanford Medicine, Stanford University
ORCID: 0000-0001-5790-4770
Observed ORCID: 0000-0001-5790-4770
OpenAlex ID: A5081064123
Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility
2015 · Dara M. Strauss-Albee, Julia Fukuyama, et al. · Science Translational Medicine · 192
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy
2023 · Nicolas Gazeau, Emily C. Liang, et al. · Transplantation and Cellular Therapy · 157
Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients
2018 · J.M. Schaenman, M. Rossetti, et al. · Human Immunology · 60
Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
2023 · Emily C. Liang, Simone E. Dekker, et al. · Blood Advances · 43
PDF
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
2023 · Emily C. Liang, Aya Albittar, et al. · Blood Advances · 36
PDF
The Frailty Risk Score predicts length of stay and need for rehospitalization after kidney transplantation in a retrospective cohort: a pilot study
2019 · Joanna Schaenman, Loren Castellon, et al. · Pilot and Feasibility Studies · 36
PDF
Lack of Proficiency in Musculoskeletal Medicine Among Emergency Medicine Physicians
2013 · Garet C. Comer, Emily Liang, et al. · Journal of Orthopaedic Trauma · 35
The newborn human NK cell repertoire is phenotypically formed but functionally reduced
2016 · Dara M. Strauss‐Albee, Emily C. Liang, et al. · Cytometry Part B Clinical Cytometry · 33
How I use next-generation sequencing–MRD to plan approach and prevent relapse after HCT for children and adults with ALL
2024 · Lori Muffly, Emily C. Liang, et al. · Blood · 31
Managing side effects: guidance for use of immunotherapies in multiple myeloma
2023 · Emily C. Liang, Surbhi Sidana · Hematology · 22
PDF
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients
2024 · Eleftheria Kampouri, Elizabeth M. Krantz, et al. · Blood · 20
PDF
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity
2024 · Emily C. Liang, Kai Rejeski, et al. · Bone Marrow Transplantation · 19
PDF
Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
2021 · Emily C. Liang, Connie Chen, et al. · Bone Marrow Transplantation · 18
PDF
Development and validation of predictive models of early immune effector cell–associated hematotoxicity
2024 · Emily C. Liang, Jennifer J. Huang, et al. · Blood Advances · 15
PDF
T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients
2022 · Harry Pickering, Joanna Schaenman, et al. · Human Immunology · 15
Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients
2018 · Emily C. Liang, Maura Rossetti, et al. · Transplantation Direct · 14
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era
2022 · Emily C. Liang, Juliana Craig, et al. · Transplantation and Cellular Therapy · 13
DNA Methylation Age Is More Closely Associated With Infection Risk Than Chronological Age in Kidney Transplant Recipients
2020 · Joanna Schaenman, Xinkai Zhou, et al. · Transplantation Direct · 13
T cell dysfunction and patient age are associated with poor outcomes after mechanical circulatory support device implantation
2018 · Joanna M. Schaenman, Maura Rossetti, et al. · Human Immunology · 11
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL
2025 · Jordan Gauthier, Emily C. Liang, et al. · Blood Advances · 10
Real-World Comparison of Lisocabtagene Maraleucel (Liso-Cel) and Axicabtagene Ciloleucel (Axi-Cel): Efficacy & Toxicity
2024 · Andrew J. Portuguese, Aya Albittar, et al. · Transplantation and Cellular Therapy · 9
Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
2021 · Emily C. Liang, Lori S. Muffly, et al. · Transplantation and Cellular Therapy · 9
Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression
2020 · Emily Liang, Mihaela Taylor, et al. · Lupus Science & Medicine · 9
PDF
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma
2025 · Andrew J. Portuguese, Emily C. Liang, et al. · Haematologica · 8
PDF
Immune-mediated necrotising myopathy: a rare cause of hyperCKaemia
2018 · Emily Liang, Mandana Rastegar · BMJ Case Reports · 8
Works count: 111
Citation count: 944
H-index: 15
I10-index: 20
Year
Topic
Type